These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 30478010)
1. Age-related variations in gene expression patterns of renal cell carcinoma. Feulner L; Najafabadi HS; Tanguay S; Rak J; Riazalhosseini Y Urol Oncol; 2019 Feb; 37(2):166-175. PubMed ID: 30478010 [TBL] [Abstract][Full Text] [Related]
2. Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma. Wu P; Liu JL; Pei SM; Wu CP; Yang K; Wang SP; Wu S BMC Cancer; 2018 Mar; 18(1):287. PubMed ID: 29534679 [TBL] [Abstract][Full Text] [Related]
3. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma. Liu J; Liu Z; Liu Q; Li L; Fan X; Wen T; An G Oncol Rep; 2018 Oct; 40(4):2023-2035. PubMed ID: 30066941 [TBL] [Abstract][Full Text] [Related]
4. New mechanistic insights of clear cell renal cell carcinoma from integrated miRNA and mRNA expression profiling studies. Qi Y; Wang L; Wang K; Peng Z; Ma Y; Zheng Z; Shang D; Xu W; Zheng J Biomed Pharmacother; 2019 Mar; 111():821-834. PubMed ID: 30616081 [TBL] [Abstract][Full Text] [Related]
5. A pan-kidney cancer study identifies subtype specific perturbations on pathways with potential drivers in renal cell carcinoma. Zhan X; Liu Y; Yu CY; Wang TF; Zhang J; Ni D; Huang K BMC Med Genomics; 2020 Dec; 13(Suppl 11):190. PubMed ID: 33371886 [TBL] [Abstract][Full Text] [Related]
6. Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy. Reustle A; Di Marco M; Meyerhoff C; Nelde A; Walz JS; Winter S; Kandabarau S; Büttner F; Haag M; Backert L; Kowalewski DJ; Rausch S; Hennenlotter J; Stühler V; Scharpf M; Fend F; Stenzl A; Rammensee HG; Bedke J; Stevanović S; Schwab M; Schaeffeler E Genome Med; 2020 Mar; 12(1):32. PubMed ID: 32228647 [TBL] [Abstract][Full Text] [Related]
7. Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes. Ho TH; Serie DJ; Parasramka M; Cheville JC; Bot BM; Tan W; Wang L; Joseph RW; Hilton T; Leibovich BC; Parker AS; Eckel-Passow JE Ann Oncol; 2017 Mar; 28(3):604-610. PubMed ID: 27993815 [TBL] [Abstract][Full Text] [Related]
8. Global analysis of metastasis-associated gene expression in primary cultures from clinical specimens of clear-cell renal-cell carcinoma. Tan X; Zhai Y; Chang W; Hou J; He S; Lin L; Yu Y; Xu D; Xiao J; Ma L; Wang G; Cao T; Cao G Int J Cancer; 2008 Sep; 123(5):1080-8. PubMed ID: 18546293 [TBL] [Abstract][Full Text] [Related]
9. Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms. Koch E; Finne K; Eikrem Ø; Landolt L; Beisland C; Leh S; Delaleu N; Granly M; Vikse BE; Osman T; Scherer A; Marti HP Am J Physiol Renal Physiol; 2019 May; 316(5):F1053-F1067. PubMed ID: 30838877 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma. Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930 [TBL] [Abstract][Full Text] [Related]
11. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis. Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363 [TBL] [Abstract][Full Text] [Related]
12. Exploring the mechanism of clear cell renal cell carcinoma metastasis and key genes based on multi-tool joint analysis. Yang H; Li W; Lv Y; Fan Q; Mao X; Long T; Xie L; Dong C; Yang R; Zhang H Gene; 2019 Dec; 720():144103. PubMed ID: 31491435 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis. Zhou L; Liu S; Li X; Yin M; Li S; Long H Mol Med Rep; 2019 May; 19(5):3485-3496. PubMed ID: 30896867 [TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis and verification of gene targets for renal clear cell carcinoma. Li F; Jin Y; Pei X; Guo P; Dong K; Wang H; Chen Y; Guo P; Meng LB; Wang Z Comput Biol Chem; 2021 Jun; 92():107453. PubMed ID: 33636636 [TBL] [Abstract][Full Text] [Related]
15. Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis. Wang S; Yu ZH; Chai KQ Biomed Res Int; 2019; 2019():6480865. PubMed ID: 30895194 [TBL] [Abstract][Full Text] [Related]
16. CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases. Wuttig D; Zastrow S; Füssel S; Toma MI; Meinhardt M; Kalman K; Junker K; Sanjmyatav J; Boll K; Hackermüller J; Rolle A; Grimm MO; Wirth MP Int J Cancer; 2012 Sep; 131(5):E693-704. PubMed ID: 22213152 [TBL] [Abstract][Full Text] [Related]
17. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management. Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154 [TBL] [Abstract][Full Text] [Related]
18. Systematic Expression Analysis of Mitochondrial Complex I Identifies NDUFS1 as a Biomarker in Clear-Cell Renal-Cell Carcinoma. Ellinger J; Poss M; Brüggemann M; Gromes A; Schmidt D; Ellinger N; Tolkach Y; Dietrich D; Kristiansen G; Müller SC Clin Genitourin Cancer; 2017 Aug; 15(4):e551-e562. PubMed ID: 28063846 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma. Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447 [TBL] [Abstract][Full Text] [Related]